North America OTC Hyaluronic Acid Market Is Slated To Witness Tremendous Growth In Future
North America OTC Hyaluronic Acid Industry The North America OTC hyaluronic acid (HA) market is projected to reach USD 10.29 billion by 2030, growing at a CAGR of 7.9% over the forecast period, according to a report by Grand View Research, Inc. The market is being driven by shifting lifestyle habits, including rising obesity rates due to sedentary behaviors, increased fast-food consumption, and alcohol use—especially among the younger population. Key Growth Drivers Expanding Orthopedic Applications Orthopedic use of HA is poised to become the most lucrative segment due to: The aging population, particularly individuals over 60, who are increasingly affected by joint disorders such as osteoarthritis and rheumatoid arthritis. Growing hospitalization rates due to arthritis, paired with greater awareness among healthcare providers of HA’s physicochemical properties. An expanding portfolio of HA-based products designed to cater specifically to joint health and mobility support. Rising...